Bonviva Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Ibandronic acid

Indications/Uses

Postmenopausal osteoporosis to reduce risk of fractures.

Click to view Bonviva detailed prescribing information

Dosage/Direction for Use

1 tab once mthly.

Click to view Bonviva detailed prescribing information

Overdosage

View Bonviva overdosage for action to be taken in the event of an overdose.

Administration

Should be taken on an empty stomach: Take at least 1 hr before the 1st food/drink/medication of the day w/ a full glass of plain water & remain in sitting/upright position for at least 1 hr. Swallow whole, do not chew/crush/suck.

Contraindications

Hypersensitivity. Esophageal abnormalities (eg, stricture or achalasia), uncorrected hypocalcemia, inability to stand or sit upright for at least 60 min.

Click to view Bonviva detailed prescribing information

Special Precautions

Discontinue use if dysphagia, odynophagia, retrosternal pain, new or worsening heartburn develops. Active upper GI problems (eg, Barrett's esophagus, dysphagia, other esophageal diseases, gastritis, duodenitis or ulcers). Osteonecrosis of the jaw & external auditory canal; cancer diagnosis, co-morbid disorders eg, anemia, coagulopathy, infection, pre-existing dental disease; dental surgery; infection or trauma; chronic ear infections. Treat hypocalcemia & other bone & mineral metabolism disturbances prior to treatment. Ensure adequate intake of Ca or vit D. Concomitant use w/ NSAIDs; chemotherapy including angiogenesis inhibitors, RT, corticosteroids. Severe renal impairment (CrCl <30 mL/min). Not to be used during pregnancy & lactation. Childn <18 yr.

Click to view Bonviva detailed prescribing information

Use In Pregnancy & Lactation

Click to view Bonviva detailed prescribing information

Adverse Reactions

GERD, diarrhoea, abdominal pain, dyspepsia, nausea, flatulence; headache; flu-like illness, fatigue; arthralgia, myalgia; rash.

Click to view Bonviva detailed prescribing information

Drug Interactions

Interfered absorption w/ Ca-, Al-, Mg-, Fe-containing products including milk & food. Increased bioavailability w/ IV ranitidine. Concomitant use w/ aspirin, NSAIDs, H₂-blockers, PPIs.

Click to view Bonviva detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Bonviva detailed prescribing information

Storage

View Bonviva storage conditions for details to ensure optimal shelf-life.

Description

View Bonviva description for details of the chemical structure and excipients (inactive components).

Action

View Bonviva mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BA06 - ibandronic acid ; Belongs to the class of bisphosphonates. Used in the treatment of bone diseases.

Regulatory Classification

Presentation/Packing

Form

Bonviva FC tab 150 mg

Packing/Price

1's

Bonviva

ibandronic acid

Manufacturer:

Pharmanovia

Distributor:

DKSH